Analysis of the processing of seven human tumor antigens by intermediate proteasomes

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3538-3547

  Guillaume, Benoît ^a,b,c   Stroobant, Vincent ^a,b,c,d   Bousquet Dubouch, Marie Pierre ^e,f   Colau, Didier ^a,b,c   Chapiro, Jacques ^a,b,c   Parmentier, Nicolas ^a,b,c   Dalet, Alexandre ^a,b,c   Van Den Eynde, Benoît J ^a,b,c,d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d Walloon Excellence in Life Sciences and Biotechnology   (Belgium)

^e INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^f UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1I PROTEIN; BETA2I PROTEIN; BETA5I PROTEIN; CHYMOTRYPSIN; GLYCOPROTEIN GP 100[209-217]; IMMUNOPROTEASOME; MELAN A[26-35]; MELANOMA ANTIGEN A3[114-122]; MELANOMA ANTIGEN C2[336-344]; MELANOMA ANTIGEN C2[42-50]; PROTEASOME; TUMOR ANTIGEN; TYROSINASE[369-377]; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; GP100 MELANOMA ANTIGEN; HEK293 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MART-1 ANTIGEN; MELANOMA; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84866534644     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103213     Document Type: Article

References (27)

1. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17: 739-779. (Pubitemid 29241139)
2. Groll, M., L. Ditzel, J. Löwe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463-471. (Pubitemid 27164066)
3. York, I. A., A. L. Goldberg, X. Y. Mo, and K. L. Rock. 1999. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172: 49-66. (Pubitemid 30000468)
4. Dick, T. P., A. K. Nussbaum, M. Deeg, W. Heinemeyer, M. Groll, M. Schirle, W. Keilholz, S. Stevanović, D. H. Wolf, R. Huber, et al. 1998. Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem. 273: 25637-25646. (Pubitemid 28475784)
5. Morel, S., F. Lévy, O. Burlet-Schiltz, F. Brasseur, M. Probst-Kepper, A.-L. Peitrequin, B. Monsarrat, R. Van Velthoven, J.-C. Cerottini, T. Boon, et al. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12: 107-117. (Pubitemid 30069219)
6. Van den Eynde, B. J., and S. Morel. 2001. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr. Opin. Immunol. 13: 147-153. (Pubitemid 32176032)
7. Schultz, E. S., J. Chapiro, C. Lurquin, S. Claverol, O. Burlet-Schiltz, G. Warnier, V. Russo, S. Morel, F. Lévy, T. Boon, et al. 2002. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J. Exp. Med. 195: 391-399. (Pubitemid 34461293)
8. Chapiro, J., S. Claverol, F. Piette, W. Ma, V. Stroobant, B. Guillaume, J.-E. Gairin, S. Morel, O. Burlet-Schiltz, B. Monsarrat, et al. 2006. Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J. Immunol. 176: 1053-1061. (Pubitemid 43099706)
9. Chapatte, L., M. Ayyoub, S. Morel, A. L. Peitrequin, N. Lévy, C. Servis, B. J. Van den Eynde, D. Valmori, and F. Lévy. 2006. Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses. Cancer Res. 66: 5461-5468. (Pubitemid 43844974)
10. Murata, S., K. Sasaki, T. Kishimoto, S. Niwa, H. Hayashi, Y. Takahama, and K. Tanaka. 2007. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 316: 1349-1353. (Pubitemid 46871657)
11. Guillaume, B., J. Chapiro, V. Stroobant, D. Colau, B. Van Holle, G. Parvizi, M. P. Bousquet-Dubouch, I. Théate, N. Parmentier, and B. J. Van den Eynde. 2010. Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc. Natl. Acad. Sci. USA 107: 18599-18604.
12. Ma, W., C. Germeau, N. Vigneron, A.-S. Maernoudt, S. Morel, T. Boon, P. G. Coulie, and B. J. Van den Eynde. 2004. Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. Int. J. Cancer 109: 698-702. (Pubitemid 38405616)
13. Ma, W., N. Vigneron, J. Chapiro, V. Stroobant, C. Germeau, T. Boon, P. G. Coulie, and B. J. Van den Eynde. 2011. A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy. Int. J. Cancer 129: 2427-2434.
14. Zarour, H., C. De Smet, F. Lehmann, M. Marchand, B. Lethé, P. Romero, T. Boon, and J.-C. Renauld. 1996. The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. J. Invest. Dermatol. 107: 63-67. (Pubitemid 26236096)
15. Wölfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.-H. Meyer zum Büschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24: 759-764. (Pubitemid 24076646)
16. Hendil, K. B., and W. Uerkvitz. 1991. The human multicatalytic proteinase: affinity purification using a monoclonal antibody. J. Biochem. Biophys. Methods 22: 159-165.
17. Bousquet-Dubouch, M. P., S. Uttenweiler-Joseph, M. Ducoux-Petit, M. Matondo, B. Monsarrat, and O. Burlet-Schiltz. 2008. Purification and proteomic analysis of 20S proteasomes from human cells. Methods Mol. Biol. 432: 301-320.
18. Bousquet-Dubouch, M. P., E. Baudelet, F. Guérin, M. Matondo, S. Uttenweiler-Joseph, O. Burlet-Schiltz, and B. Monsarrat. 2009. Affinity purification strategy to capture human endogenous proteasome complexes diversity and to identify proteasome-interacting proteins. Mol. Cell. Proteomics 8: 1150-1164.
19. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105. (Pubitemid 17196641)
20. Rock, K. L., D. J. Farfán-Arribas, and L. Shen. 2010. Proteases in MHC class I presentation and cross-presentation. J. Immunol. 184: 9-15.
21. Gaczynska, M., K. L. Rock, T. Spies, and A. L. Goldberg. 1994. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc. Natl. Acad. Sci. USA 91: 9213-9217. (Pubitemid 24297884)
22. Toes, R. E. M., A. K. Nussbaum, S. Degermann, M. Schirle, N. P. N. Emmerich, M. Kraft, C. Laplace, A. Zwinderman, T. P. Dick, J. Müller, et al. 2001. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12. (Pubitemid 32660433)
23. Corbière, V., J. Chapiro, V. Stroobant, W. Ma, C. Lurquin, B. Lethé, N. van Baren, B. J. Van den Eynde, T. Boon, and P. G. Coulie. 2011. Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases. Cancer Res. 71: 1253-1262.
24. Groll, M., O. V. Larionov, R. Huber, and A. de Meijere. 2006. Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation. Proc. Natl. Acad. Sci. USA 103: 4576-4579.
25. Sijts, A. J. A. M., T. Ruppert, B. Rehermann, M. Schmidt, U. Koszinowski, and P.-M. Kloetzel. 2000. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 191: 503-514.
26. Gaczynska, M., K. L. Rock, and A. L. Goldberg. 1993. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365: 264-267. (Pubitemid 23282087)
27. Seifert, U., L. P. Bialy, F. Ebstein, D. Bech-Otschir, A. Voigt, F. Schröter, T. Prozorovski, N. Lange, J. Steffen, M. Rieger, et al. 2010. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142: 613-624.